LAST PRICE - AT THE CLOSE
DRUG is DOWN -1% since the begininning of the year
DRUG is DOWN -0% BELOW 20 day SMA
DRUG is DOWN 0% BELOW 200 day SMA
PROFITABLE: NO
EPS: $-0.173079
EARNINGS MOMENTUM: YES
0.84% INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
 |
THE STOCK IS 37.4% AWAY FROM ALL-TIME HIGHS OF $123.75 |
 |
DRUG IS DOWN -1% SINCE THE BEGINNING OF THE YEAR |
 |
DRUG IS UP 76% OVER THE PAST 12 MONTHS |
 |
DRUG IS UP 9% OVER THE PAST 1 MONTH |
 |
13% OF ALL DRUG INVESTORS ARE BETTING AGAINST DRUG |
 |
NUM INVESTORS SHORT DRUG HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|
 |
DRUG moved down N/A in the previous minute |
 |
DRUG is up N/A over the last hour |
 |
DRUG is up 100% over the last 5 days |
 |
DRUG is 100 above its 8 day SMA |
| $0.00 | DAY |
$0.00 |
| $77.23 |  PREVIOUS DAY |
$79.56 |
| $75.50 | WEEK |
$87.00 |
| $68.80 | MONTH |
$87.00 |
| $38.00 | YEAR |
$123.75 |
DRUG is mentioned N/A less than normal on 
DRUG is mentioned N/A times in an average day on 
